Transdermal Drug Delivery System Market is Expected to Show a Significant Growth During the Forecast Period 2021 – 2024
Global Transdermal Drug Delivery System Market is anticipated to reach USD 81.4 billion by 2024 owing to shift toward sedentary lifestyle that encourages chronic disorders. Transdermal drug delivery is a painless process of delivering drug in the body part. TDDS delivers drug through the skin in pre-decided and regulated rate. It offers extended therapeutic effects, lesser side-effects, improved patient compliance, better bioavailability, and easy cessation of drug treatment. Transdermal drug delivery is much preferred today as compared to the conventional oral method or injectables.
Transdermal drug
delivery systems market is witnessing growth due to the factors like increasing
consumer preference for minimally invasive procedures for chronic disorders and
multiple advantages associated with TDDS. Infusion of drug could be effectively
monitored and projected creditably through transdermal drug delivery method,
which makes it convenient to maintain steady level of drug. However,
transdermal drug delivery system industry is restrained by constrained areas of
delivery and slow infusion rate hydrophilic drugs.
Request a Sample Copy
of Transdermal Drug Delivery System Market Report @ https://www.millioninsights.com/industry-reports/transdermal-drug-delivery-system-market/request-sample
Recent years has introduced multiple drugs
that could be delivered through transdermal route. Also, the existing market
players in this market are focusing on mergers and acquisition to create niche
market. Transdermal drug delivery system market is categorized on the basis of
delivery system type, application, and geography.
Global
Transdermal Drug Delivery Systems Product Outlook (Revenue, USD Billion, 2013 -
2024)
•
Electroporation
•
Radiofrequency
•
Iontophoresis
•
Microporation
•
Thermal
•
Mechanical arrays
•
Ultrasound
• Others
Global
Transdermal Drug Delivery Systems Application Outlook (Revenue, USD Billion,
2013 - 2024)
•
Central nervous system
•
Pain management
•
Cardiovascular
•
Hormone
• Others
The prominent players in transdermal drug delivery systems industry include Acrux Limited, Echo Therapeutics, Inc., Johnson & Johnson, Bristol-Myers Squibb Company, GlaxoSmithKline plc, Boehringer Ingelheim GmbH, Mylan N.V., Bayer AG, Endo Pharmaceuticals Inc. and Novartis AG.
Access Transdermal Drug
Delivery System Market Report with TOC @ https://www.millioninsights.com/industry-reports/transdermal-drug-delivery-system-market
Transdermal
Drug Delivery Systems Regional Outlook (Revenue, USD Billion, 2013 - 2024)
•
North America
• U.S.
• Canada
•
Europe
• UK
• Germany
•
Asia Pacific
• Japan
• China
• India
•
Latin America
• Mexico
• Brazil
•
MEA
• South Africa
Comments
Post a Comment